The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 05, 2019

Filed:

Dec. 14, 2017
Applicant:

Tsung-min Hsu, Taipei, TW;

Inventor:

Tsung-Min Hsu, Taipei, TW;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/70 (2006.01); A61P 25/28 (2006.01); A61K 31/27 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); C07C 269/08 (2006.01); C07C 271/44 (2006.01);
U.S. Cl.
CPC ...
C07C 269/08 (2013.01); A61K 9/0014 (2013.01); A61K 9/7053 (2013.01); A61K 9/7084 (2013.01); A61K 31/27 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61P 25/28 (2018.01); C07C 271/44 (2013.01);
Abstract

The present invention provides a method for producing an active ingredient for a rivastigmine free base transdermal patch having preparing a rivastigmine free base; and adding an acidic substance to the rivastigmine free base and subjecting the acidic substance and the rivastigmine free base to a mixed reaction to form a mixture having a pH value from 6.0 to 8.5 as the active ingredient; and a rivastigmine free base transdermal patch having a drug layer comprising the active ingredient. The rivastigmine free base transdermal patch has a stable transdermal transmission time equal to or longer than 48 hours and equal to or less than 168 hours. The active ingredient produced by the method and the transdermal patch having the active ingredient allow effective and smooth release of rivastigmine free base and prolongs the release time to meet the clinical application needs.


Find Patent Forward Citations

Loading…